Jun 10, 2024, 16:08
It was great to catch up with Mazyar Shadman at ASCO24 – VJHemOnc
VJHemOnc shared a post on X:
“It was great to catch up with Mazyar Shadman at ASCO24 to find out if BTK inhibitors are a suitable treatment option for patients with CLL and cardiovascular comorbidities.
Click here to watch.”
Source: VJHemOnc/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 19, 2024, 08:27
Dec 19, 2024, 08:12
Dec 19, 2024, 08:08
Dec 19, 2024, 07:51
Dec 19, 2024, 07:45
Dec 19, 2024, 07:38
Dec 19, 2024, 07:27
Dec 19, 2024, 07:24